GOSS · Gossamer Bio Inc
United States · RS rating 94 · As of 2026-11-03
| Price | 9.28 USD |
|---|---|
| 1-day change | -1.8% |
| RS rating (overall / 1M / 3M / 12M) | 94 / 30 / 99 / 98 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 37 / 74 / 36 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | +3.8% |
| Distance from 52-week high | +22.3% |
| Market cap (USD) | $87.7M |